SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-011441
Filing Date
2023-03-31
Accepted
2023-03-31 17:24:52
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 vktx-2023-03-29-424b5_fi.htm 424B5 888414
2 GRAPHIC img8845167_0.jpg GRAPHIC 13142
3 GRAPHIC img8845167_1.jpg GRAPHIC 78498
4 GRAPHIC img8845167_2.jpg GRAPHIC 13142
5 GRAPHIC img8845167_3.jpg GRAPHIC 4119
  Complete submission text file 0000950170-23-011441.txt   1039888
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258231 | Film No.: 23789293
SIC: 2834 Pharmaceutical Preparations